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1. Introduction 
Oculocutaneous albinism is classified into non-syndromic oculocutaneous albinism (OCA) 
and syndromic OCA including Hermansky-Pudlak syndrome (HPS), Chediak-Higashi 
syndrome (CHS) and Griscelli syndrome (GS). Both non-syndromic and syndromic OCAs 
are autosomal recessive disorders. Human HPS is genetically divided into nine forms, HPS 
type 1 (HPS-1) to HPS-9. Human HPS can be sub-classified into four subgroups which are 
associated with protein complexes encoded by the causative genes. In this session, we 
summarize (1) the clinical features of HPS, (2) the mice and rat models of HPS, and (3) the 
molecular functions. 
2. The clinical features of HPS 
In 1959, Hermansky and Pudklak described two cases of OCA associated with hemorrhagic 
diathesis.1 Currently, the condition is known as HPS. HPS is a rare heterogeneous autosomal 
recessive syndrome which is typically characterized by OCA, bleeding diathesis, and 
lysosomal ceroid storage resulting from defects of multiple cytoplasmic organelles: 
melanosomes, platelet dense core granules, and lysosomes.2 The storage of ceroid-like 
material in lysosomes induces restrictive lung disease, ulcerative colitis, kidney failure, and 
cardiomyopathy.  
Accumulation of mice models, identification of causative genes and functional analysis 
indicated that HPS could be sub-classified into four groups according to four protein 
complexes, biogenesis of lysosome-related organelles complex-3 (BLOC-3) (HPS-1 and HPS-
4), adaptor protein-3 (AP-3) (HPS-2), BLOC-2 (HPS-3, HPS-5 and HPS-6) and BLOC-1( HPS-
7, HPS-8 and HPS-9).3-5 Currently, more than 16 mice strains and more than 2 rat strains are 
known as models of human HPS (Table 1). HPS-1 is caused by mutation in HPS1,6 HPS-2 is 
caused by mutation in AP3B1,7 HPS-3 is caused by mutation in HPS3,8 HPS-4 is caused by 
mutation in HPS4,9 HPS-5 is caused by mutation in HPS5,10 HPS-6 is caused by mutation in 
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HPS6,10 HPS-7 is caused by mutation in DTNBP1,11 HPS-8 is caused by mutation in 
BLOC1S3,12 and HPS-9 is caused by mutation in PLDN.13 Functional analyses identify that 
most of all HPS proteins construct complexes, BLOC-1, BLOC-2, BLOC-3, AP3, class C 
vacuolar protein sorting (VPS), and Rab geranylgeranyl transferase (RABGGT).  
 
Mouse models Human type Genes Protein complexes 
pale ear HPS-1 HPS1 BLOC-3 
pearl  HPS-2 AP3B1 AP3 
cocoa  HPS-3 HPS3 BLOC-2 
light ear HPS-4 HPS4 BLOC-3 
ruby-eye-2 HPS-5 HPS5 BLOC-2 
ruby-eye HPS-6 HPS6 BLOC-2 
sandy HPS-7 DTNBP1 BLOC-1 
reduced pigmentation HPS-8 BLOC1S3 BLOC-1 
pallid HPS-9 PLDN BLOC-1 
buff ? VPS33A class C VPS 
cappuccino ? CNO BLOC-1 
gunmetal ? RABGGTA RABGGT 
misty ? DOCK7  
mocha ? AP3D1 AP3 
muted ? MUTED BLOC-1 
subtle gray ? SLC7A11  
Rat models    
Fawn-Hooded rat ? RAB38  
Tester-Moriyama rat ? RAB38  
Table 1. Animal models, human types, causative genes and their protein complexes in HPS. 
HPS-1 and HPS-4, the group of BLOC-3, are the most dominant and typical subtypes. The 
founder effect in HPS-1 is present in the region of northwest Puerto Rico.8 HPS-1 and HPS-4 
are characterized by OCA by deficiency of melanosomes, bleeding by loss of platelet dense 
core granules, and systemic organ involvement (restrictive lung disease, granulomatous 
colitis, kidney failure, and cardiomyopathy) by the storage of lysosomal ceroid-like 
substances due to impaired lysosomes. The clinical features of OCA and bleeding diathesis 
are present in infancy. Bleeding tendency is important to diagnose.  
HPS-2, the group of AP3, is the most severe and rare subtype, with 15 cases reported in the 
literature.14 Clinical manifestations include OCA, a platelet storage pool defect, interstitial 
lung disease, and recurrent bacterial and viral infections due to immunodeficiency.14 
Patients with HPS-2 exhibit neutropenia that is responsive to granulocyte colony-
stimulation factor, deficiency of natural killer and natural killer T-cells, T-lymphocyte 
dysfunction, and in one case hemophagocytic lymphohistiocytosis.14  
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HPS-3, HPS-5, and HPS-6, the group of BLOC-2, are the milder and relatively rare subtypes. 
The founder effect in HPS-3 is present in the area of central Puerto Rico.8 HPS-3, HPS-5 and 
HPS-6 are relatively milder forms of the disease in that both OCA and bleeding diathesis are 
mild and pulmonary fibrosis and granulomatous colitis generally does not develop.10, 15-17  
HPS-7, HPS-8, and HPS-9, the group of BLOC-1, are extremely rare subtypes. HPS-7 is only 
found in a 48-year-old Portuguese woman with OCA, a bleeding tendency, mild shortness 
of breath on exertion and reduced lung compliance but otherwise normal pulmonary 
function.11 HPS-8 is found in a Pakistani family12 and an Iranian patient.18 HPS-8 is 
characterized by typical OCA and a bleeding diathesis. Pulmonary fibrosis, granulomatous 
colitis, or neutropenia are not detected in the cases. 12, 18 HPS-9 is only found in a 9-month-
old male of Indian ancestry.13 The patient showed OCA with generalized hypopigmentation, 
nystagmus, iris transillumination, and retinal hypopigmentation; respiratory distress 
requiring a 3 week admission to a neonatal intensive-care unit for respiratory support; and 
platelet electron microscopy showing absent platelet delta granules.13  
Recombinant factor VIIa (rFVIIa) is useful for dangerous bleeding such as refractory 
menorrhagia.19 Progressive HPS-1 pulmonary fibrosis is effectively treated by pirfenidone, a 
small molecule that inhibits TGF-beta-mediated fibroblast proliferation and collagen 
synthesis in vitro.20 Infliximab is effective for granulomatous colitis in HPS patients.21 The 
efficacy of infliximab suggests that TNF-α plays a pivotal role in the pathogenesis.21 
3. The mice and rat models of HPS 
Mice models of HPS can be grouped into BLOC-3 (pale ear22, 23 and light ear9), BLOC-2 (cocoa24, 
ruby-eye-210 and ruby-eye10), BLOC-1 (sandy11, reduced pigmentation25, pallid26, cappuccino27 and 
muted28), AP-3 (pearl29 and mocha30), class C VPS (buff31), RABGGT (gunmetal32), and others 
(misty33 and subtle gray34) (Table 1). Two rat models of HPS, Fawn-Hooded Rat and Tester-
Moriyama Rat, are genetically identical with no expression of RAB38.35  
Gautam et al. contacted mutant mice doubly or triply deficient in protein subunits of the 
various BLOC complexes and/or the AP-3 adaptor complex and tested for viability and for 
abnormalities of lysosome-related organelles (LROs) including melanosomes, lamellar 
bodies of lung type II cells and platelet dense granules.36 They showed that double and 
triple mutant HPS mice provide unique and practical experimental advantages in the study 
of LROs.36 Long-Evans Cinnamon rats with a point mutation in the initiation codon of Rab38 
small GTPase are investigated for the pathogenesis of interstitial pneumonia via aberrant 
lung surfactant secretion.37 Thus, mice and rat models are indispensable for recognizing the 
molecular function in LROs and the pathogenesis of HPS. 
4. The molecular functions 
The complexes involving in the pathogenesis of HPS are BLOC-3, BLOC-2, BLOC-1, AP-3 
adaptor complex, and class C VPS. BLOC-3 is composed of HPS1/pale ear and HPS4/light 
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ear.38-40 BLOC-2 conprises HPS3/cocoa, HPS5/ruby-eye-2 and HPS6/ruby-eye.10, 41 BLOC-1 is 
constructed by proteins of HPS7/DTNBP1/sandy, HPS8/BLOC1S3/reduced pigmentation/ 
BLOS3, cappuccino, muted, pallid, BLOS1, BLOS2 and snapin.42, 43 AP-3 (subunits δ/mocha, 
β3/HPS2/ AP3B1/pearl, μ3, σ3) is one of the family of heterotetrameric clathrin adaptors.44 
The class C VPS is composed of VPS11, VPS16, VPS18, and VPS33/buff.45  
 
Figure 1. BLOC-1, -2, -3, AP-3 and class C VPS complexes involve in membrane trafficking from 
endosomes to lysosomes and lysosome-related organelles, melanosomes and dense core granules in 
platelets. 
Adaptor protein complexes are composed of heterotetramers (two large subunits, a 
medium-sized subunit and a small subunit) and sort cargo into vesicles for transport from 
one membrane compartment of the cell to another.46 AP-3 traffics cargo from tubular 
endosomes to late endosomes, lysosomes, and related organelles via the bound to BLOC-1, 
vimentin, clathrin and others.46, 47  
The class C VPS core complex (VPS33A/B, VPS11, VPS16 and VPS18) is essential for late 
endosome and lysosome assembly and for numerous endolysosomal trafficking pathways.48 
Two class C VPC complexes, homotypic fusion and protein sorting (HOPS) and class C core 
vacuole/endosome tethering (CORVET), incorporate diverse biochemical functions: they 
tether membranes, stimulate Rab nucleotide exchange, guide SNARE assembly to drive 
membrane fusion, and possibly act as ubiquitin ligases.48 
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BLOC-1 functions in selective cargo exit from early endosomes toward lysosomes and 
lysosome-related organelles such as melanosomes and BLOC-2 act sequentially in the same 
pathway.49 Melanosome maturation requires at least two cargo transport pathways directly 
from early endosomes to melanosomes, one pathway mediated by AP-3 and one pathway 
mediated by BLOC-1 and BLOC-2.49 BLOC-3 is constructed by HPS1 and HPS4 
heterodimers.50 BLOC-3 interacts with the GTP-bound form of the endosomal GTPase, Rab9. 
BLOC-3 might function as a Rab9 effector in the biogenesis of lysosome-related organelles.50 
5. Conclusion 
Now, HPS is a representative disorder of aberrant membrane trafficking. HPS genes have 
been identified with mice models. The function of encoded proteins has been accompanied 
with cell biology in yeast, worm, fly and animal models. Membrane trafficking is crucial for 
cells to survive and play their active functions. Further emerging investigation will reveal 
more precise pathogenesis in HPS. 
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